drugset
drugset / Trial / NCT00598702

Study of the Safety & Efficacy of Intravenous Acetaminophen in Pediatric Inpatients

NCT00598702 ↗

Phase 3 Completed 100 enrolled Mallinckrodt
NaSingle-groupOpen-labelTreatment

Summary

Intravenous acetaminophen (IVAPAP) is safe in repeated dose, multi-day clinical use when administered at a daily dose of 40 to 75 mg/kg body weight

Timeline

Start
2008-01
Primary completion
2008-12
Completion
2009-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 40 mg/kg Intravenous
Subject Acetaminophen Small molecule 75 mg/kg Intravenous

Indications

No indication recorded.